Lily Li

Director at Northpond Ventures

San Diego, California

Investor

Invests in

Stages:

Sectors:

Los Angeles / Southern California

Locations:

San Diego, California

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Lifesciences

Market Research

Business Strategy

Oncology

Management Consulting

Protein Chemistry

Financial Modeling

Competitive Intelligence

Infectious Diseases

Life Sciences

Healthcare

Growth Strategies

Business Development

Entrepreneurship

Project Management

Primary Research

Neurology

Forecasting

Commercial Assessment

Cardiovascular Disease

Education

Ph.D
Emory University
(2006 - 2011)
Georgia Tech Scheller College of Business
(2009 - 2011)
BS
Tsinghua University
(2002 - 2006)

Investments

Ansa Biotechnologies

Series A

Total Funding: $76M

1859

Series A

Total Funding: $40M

Personal Genome Diagnostics

Series C

Total Funding: $200M

Work Experience

Northpond Ventures

2020

Director
2023
Northpond Ventures is a multi-billion-dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has consistently been named one of the most active lead life science investors in venture industry rankings. It is deeply engaged in the academic ecosystem, having founded The Laboratory for Bioengineering Research and Innovation at the Wyss Institute at Harvard University; launched the MIT-Northpond Program – Advancing Life Science & Engineering Innovation; launched the Northpond Laboratories — Program for Research and Innovation at Stanford Medicine; and sponsored a prize for women entrepreneurs at MIT. It has led or co-led over 60 financings over the past several years and sits on the board of the vast majority of these businesses. Learn more at npv.vc. Current and former board member at: Ansa, 1859, SpeeDx, Vestaron, PGDx (acquired by LabCorp) Current board observer at: Emulate, Encodia, Delfi, Chromacode
Principal
2020 - 2023

Vestaron Corporation

2024